Depends on what THEIR overall plans are. That late

Depends on what THEIR overall plans are. That late PR was a good one in showing what strength and faith the company has in its product with 30 sites and what 189 patients (so far) to be in the trial study. Why do that if not expecting great results to be documented. Will take time of course for the time length of the study , so we can still expect market manipulation and negative posts. But THEIR plans to head the PPS down to ??? have been slowed again.